Preoperative prediction of granulation pattern subtypes in GH-secreting pituitary adenomas

Clin Endocrinol (Oxf). 2021 Jul;95(1):134-142. doi: 10.1111/cen.14465. Epub 2021 May 10.

Abstract

Objective: The aim of this study was to establish a preoperative prediction method for sparsely granulated (SG) growth hormone (GH)-secreting pituitary adenoma, an aggressive tumour subtype with high recurrence risk, in acromegaly patients.

Methods: Eighty-three patients with GH-secreting pituitary adenomas were included in this study. GH measurements, cytokeratin immunostaining and electron microscopy were performed to detect granulation patterns. Preoperative factors, including general, radiological and endocrinological features and acute octreotide suppression test outcomes, were compared between SG and densely granulated (DG) groups. The predictive capabilities of these features were analysed using a receiver operating characteristic (ROC) curve, and the most predictive features were combined to establish a grading scale.

Results: Thirty-nine of the 83 patients had SG GH-secreting pituitary adenomas; 44 had DG tumours. SG tumours tended to occur in younger patients and have larger diameters and volumes, higher Knosp grades, lower GH indexes and normalized insulin-like growth factor-1 (IGF-1) level, and a lower ∆GH% after octreotide treatment. The tumour size, Knosp grade, GH index and ∆GH% after octreotide treatment had good predictive performance, with area under the curve (AUC) values ranging from 0.70 to 0.80. Combining four parameters, including diameter, Knosp grade, GH index and ∆GH% after octreotide treatment, we established a grading scale for predicting SG GH-secreting pituitary adenomas with an AUC of 0.84 and relatively high sensitivity and specificity.

Conclusions: We propose a predictive method for distinguishing SG and DG GH-secreting pituitary adenomas preoperatively. This method will help physicians identify candidates for presurgical medical treatment and neurosurgeons determine radical surgical strategies for high-risk tumours.

Keywords: densely granulated; growth hormone; pituitary adenoma; sparsely granulated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acromegaly*
  • Adenoma* / surgery
  • Growth Hormone-Secreting Pituitary Adenoma*
  • Humans
  • Neoplasm Recurrence, Local
  • Octreotide
  • Pituitary Neoplasms* / surgery

Substances

  • Octreotide